These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 24038431)

  • 1. Using computational strategies to predict potential drugs for nasopharyngeal carcinoma.
    Lan MY; Yang WL; Lin KT; Lin JC; Shann YJ; Ho CY; Huang CY
    Head Neck; 2014 Oct; 36(10):1398-407. PubMed ID: 24038431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-silico drug screening and potential target identification for hepatocellular carcinoma using Support Vector Machines based on drug screening result.
    Yang WL; Lee YE; Chen MH; Chao KM; Huang CY
    Gene; 2013 Apr; 518(1):201-8. PubMed ID: 23220021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Momordica Charantia lectin, a type II ribosome inactivating protein, exhibits antitumor activity toward human nasopharyngeal carcinoma cells in vitro and in vivo.
    Fang EF; Zhang CZ; Ng TB; Wong JH; Pan WL; Ye XJ; Chan YS; Fong WP
    Cancer Prev Res (Phila); 2012 Jan; 5(1):109-21. PubMed ID: 21933914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin exerts inhibitory effects on undifferentiated nasopharyngeal carcinoma by inhibiting the expression of miR-125a-5p.
    Gao W; Chan JY; Wong TS
    Clin Sci (Lond); 2014 Nov; 127(9):571-9. PubMed ID: 24896104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From NPC therapeutic target identification to potential treatment strategy.
    Lan MY; Chen CL; Lin KT; Lee SA; Yang WL; Hsu CN; Wu JC; Ho CY; Lin JC; Huang CY
    Mol Cancer Ther; 2010 Sep; 9(9):2511-23. PubMed ID: 20716640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPLUNC1 is associated with nasopharyngeal carcinoma prognosis and plays an important role in all-trans-retinoic acid-induced growth inhibition and differentiation in nasopharyngeal cancer cells.
    Zhang W; Zeng Z; Wei F; Chen P; Schmitt DC; Fan S; Guo X; Liang F; Shi L; Liu Z; Zhang Z; Xiang B; Zhou M; Huang D; Tang K; Li X; Xiong W; Tan M; Li G; Li X
    FEBS J; 2014 Nov; 281(21):4815-29. PubMed ID: 25161098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma.
    Sung FL; Pang RT; Ma BB; Lee MM; Chow SM; Poon TC; Chan AT
    J Proteome Res; 2006 Dec; 5(12):3260-7. PubMed ID: 17137327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effect and enhancement of cytotoxic drug activity by cetuximab in nasopharyngeal carcinoma cells.
    Sung FL; Poon TC; Hui EP; Ma BB; Liong E; To KF; Huang DP; Chan AT
    In Vivo; 2005; 19(1):237-45. PubMed ID: 15796181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacophore-based screening targeted at upregulated FN1, MMP-9, APP reveals therapeutic compounds for nasopharyngeal carcinoma.
    Lai CJ; Tay BH
    Comput Biol Med; 2016 Feb; 69():158-65. PubMed ID: 26773938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of an oral allosteric AKT inhibitor (MK-2206) on human nasopharyngeal cancer in vitro and in vivo.
    Zhao YY; Tian Y; Zhang J; Xu F; Yang YP; Huang Y; Zhao HY; Zhang JW; Xue C; Lam MH; Yan L; Hu ZH; Dinglin XX; Zhang L
    Drug Des Devel Ther; 2014; 8():1827-37. PubMed ID: 25336925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of candidate molecular markers of nasopharyngeal carcinoma by microarray analysis of subtracted cDNA libraries constructed by suppression subtractive hybridization.
    Zhou Y; Zeng Z; Zhang W; Xiong W; Li X; Zhang B; Yi W; Xiao L; Wu M; Shen S; Li X; Cao L; Tang K; Li G
    Eur J Cancer Prev; 2008 Nov; 17(6):561-71. PubMed ID: 18941378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of BCL-2 synergizes cisplatin sensitivity in nasopharyngeal carcinoma cells.
    Low SY; Tan BS; Choo HL; Tiong KH; Khoo AS; Leong CO
    Cancer Lett; 2012 Jan; 314(2):166-75. PubMed ID: 22033244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic role of Epstein-Barr virus-encoded small RNAs (EBERs) in nasopharyngeal carcinoma.
    Yoshizaki T; Endo K; Ren Q; Wakisaka N; Murono S; Kondo S; Sato H; Furukawa M
    Auris Nasus Larynx; 2007 Mar; 34(1):73-8. PubMed ID: 17129696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of novel UBAP1 protein and its decreased expression on nasopharyngeal carcinoma tissue microarray.
    Xiao B; Fan S; Zeng Z; Xiong W; Cao L; Yang Y; Li W; Wang R; Tang K; Qian J; Shen S; Li X; Li G
    Protein Expr Purif; 2006 May; 47(1):60-7. PubMed ID: 16226037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minicircle-IFNgamma induces antiproliferative and antitumoral effects in human nasopharyngeal carcinoma.
    Wu J; Xiao X; Zhao P; Xue G; Zhu Y; Zhu X; Zheng L; Zeng Y; Huang W
    Clin Cancer Res; 2006 Aug; 12(15):4702-13. PubMed ID: 16899621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs.
    Murono S; Raab-Traub N; Pagano JS
    Cancer Res; 2001 Nov; 61(21):7875-7. PubMed ID: 11691806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of KIAA1173 gene expression in nasopharyngeal carcinoma tissues and cell lines on tissue microarray].
    Zhang SQ; Peng H; Song LY; Li XM; Jiang HY; Yao KT; Zhao T
    Ai Zheng; 2005 Nov; 24(11):1322-6. PubMed ID: 16552956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolin antisense oligodeoxynucleotides induce apoptosis and may be used as a potential drug for nasopharyngeal carcinoma therapy.
    Wu CD; Chou HW; Kuo YS; Lu RM; Hwang YC; Wu HC; Lin CT
    Oncol Rep; 2012 Jan; 27(1):94-100. PubMed ID: 21956494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binary/ternary combined effects of vitamin K3 with other antitumor agents in nasopharyngeal carcinoma CG1 cells.
    Liao WC; Wu FY; Wu CW
    Int J Oncol; 2000 Aug; 17(2):323-8. PubMed ID: 10891542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.